Inventor · disambiguated record
Genoveffa Franchini
Also filed as: FRANCHINI GENOVEFFA
10 granted patents·11 pending applications·171 citations·filing 1989–2024
90Inventor score
Top patents by PatentIndex Score
21 records- 0188US6596279B1Immunodeficiency recombinant poxvirusVIROGENETICS CORP·Filed 1998·Granted Jul 22, 2003·68 cites·23 claims
- 0287US7790182B2Protein vaccines against poxvirusesUS ARMY·Filed 2006·Granted Sep 7, 2010·8 cites·14 claims
- 0384US7094408B2Immunogenicity using a combination of DNA and vaccinia virus vector vaccinesUS HEALTH·Filed 2001·Granted Aug 22, 2006·12 cites·14 claims
- 0483US7771729B2Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectorsUS HEALTH·Filed 2006·Granted Aug 10, 2010·2 cites·14 claims
- 0578US5420030AMolecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereofUS HEALTH·Filed 1993·Granted May 30, 1995·30 cites·10 claims
- 0670US5223423ACharacterization of replication competent human immunodeficiency type 2 proviral clone hiv-2sbl/isyUS HEALTH·Filed 1989·Granted Jun 29, 1993·27 cites·3 claims
- 0764US5576000AMolecular clones of HIV-1 viral strains MH-ST1 and BA-L, and uses thereofUS HEALTH·Filed 1995·Granted Nov 19, 1996·17 cites·5 claims
- 0861US2025109175A1Recombinant gp120 protein with v1-loop deletionTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 0961US2003223987A1Immunodeficiency recombinant poxvirusFiled 2003·Application pending·0 cites
- 1061US2008188640A1Immunodeficiency recombinant poxvirusPAOLETTI ENZO·Filed 2007·Application pending·0 cites
- 1156US12162910B2Recombinant gp120 protein with V1-loop deletionUS HEALTH·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 1255US2024277829A1Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infectionUS HEALTH·Filed 2022·Application pending·0 cites
- 1354US2025302939A1Vaccine for human t-lymphotropic virus-1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2023·Application pending·0 cites
- 1451US2006094006A1Immunotherapy regimens in hiv-infected patientsFRANCHINI GENOVEFFA·Filed 2003·Application pending·0 cites
- 1550US5869313AMolecular clones of HIV-1 viral strains MN-ST1 and BA-L, and uses thereofUS HEALTH·Filed 1996·Granted Feb 9, 1999·7 cites·14 claims
- 1647US2010291037A1Immunogenicity using a combination of dna and vaccinia virus vector vaccinesUS OF AMERICA AS REPRESENTED B·Filed 2010·Application pending·0 cites
- 1746US2005019752A1Novel chimeric rev, tat, and nef antigensFiled 2002·Application pending·0 cites
- 1843US2006205070A1HIV TEV compositions and methods of useUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 1941US2011081368A1Protein vaccines against poxvirusesHOOPER JAY W·Filed 2010·Application pending·0 cites
- 2038US10398772B2Ras pathways as markers of protection against HIV and methods to improve vaccine efficacyUS HEALTH·Filed 2015·Granted Sep 3, 2019·0 cites·25 claims
- 2130US2014286991A1Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hivPODACK ECKHARD R·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →